Head of Data Science- Commercial,
Medical & Government Affairs
Executive Director, Omnichannel Strategy & Innovation
Director, Global Data Science
Director, Global Integrated Insights
Director, Global Field Capabilities & Excellence
Head, Global Medical Communications
Executive Director, Head Digital Medical Affairs
Head of Worldwide Medical Technology & Analytics
Head of Commercial IT
Machine Learning Product Management Principal
Director, Commercial Advanced Analytics
Healthcare & Life Sciences
CEO & Co-founder
Managing Director, Life Science Advertising, Marketing & Commerce
Life Sciences, Med Device & Digital Health Practice Lead
EVP, Commercial Strategy
Merrill Brown is the Editorial Director of G/O Media and oversees a portfolio of high profile media outlets, including Gizmodo, The Onion and Deadspin. He launched MSNBC.com and was the website’s founding Editor-in-Chief. He is the former Director of the School of Communication and Media at Montclair State University, and the Co-founder of the Online News Association.
Dr. Tamayo-Sarver focuses on healthcare innovation that leverages technology through strategic partnership, investment, or internal incubation. He is passionate about transforming healthcare so that every encounter is productive and positive for the patient, the provider, and the system.
Registration desk opens and breakfast is provided
Join us in the networking hub for breakfast prior to sessions beginning.
Mark Miller, Deloitte
The rate of change in pharma continues to accelerate with new innovations coming at us seemingly every day. What are the big trends and disruptions we all need to understand and be prepared for? How can your Commercial and Medical organizations future-proof your strategies? Mark Miller from Deloitte will help answer these questions by sharing insights and research on the most significant opportunities and challenges that lie ahead.
John Vitalie, Aktana | Derek Choy, Aktana
Hyper-personalized relationships and increasingly impactful engagement are table stakes for both commercial and medical teams. With all the opportunities that lie ahead for our industry, how is Aktana driving critical innovation that shapes how we engage and interact with our customers?
Youssef Idelcaid, Genentech
What does the path to commercial transformation look like in a digital and AI obsessed world? Genentech's Youssef Idelcaid discusses the journey, lessons learned, and innovative ways they are using technology to drive impact for the organization.
Stacy Stone, BeiGene | John Walsh, Otsuka | Scott Torrie, Genentech | Moderator: Alan Kalton, Aktana
Commercial transformation programs come with both big wins and lessons learned. With the benefit of hindsight, panelists share their experiences with hurdles to overcome, essential investments to be made, and must-have best practices to achieve success.
Lunch will be provided on site.
Join your peers in the Hub for great food and conversation
Session tracks are detailed below the main agenda.
Choose one of three tracks: Commercial, Medical Affairs or Data Science & Analytics.
Jeevaka Kiriella, Merck | Allen Kumar, Biogen | Graham Rapier, Aktana
A true omnichannel engagement can only happen when every group that interacts with an HCP is coordinated and orchestrated to provide maximum impact. Our panelists will share their perspectives and experiences on breaking down internal organizational silos to holistically put the customer at the center and ultimately drive the highest value for both the HCP and the business.
Merrill Brown, G/O Media
In this fireside-chat, Merrill will share how content, from development to consumption, is evolving in the world of general media. Learn how the life sciences industry can better prepare for the everchanging content landscape from an expert who has been at the center of this transformation on a global scale.
Drinks followed by dinner at Elsie Rooftop
Join us in the Hub as we wrap up day one with your beverage of choice (+apps), and then we'll see you at Elsie Rooftop for dinner and fun with an iconic city view.
Breakfast is served in the Hub
Join us in the networking hub for breakfast prior to sessions beginning.
Kick off day 2 with a quick recap and key takeaways from day 1 content and discussions.
Dr. Joshua Tamayo-Sarver
AI is already reaching far into the world of HCPs, from diagnostic and treatment support to influencing how and when they are marketed to. Dr. Tamayo-Sarver is embracing the revolution and pushing the limits. He will share his first hand experiences with the opportunities and challenges of AI in healthcare.
In this session, the audience will split into different cross-functional groups and be tasked to work through and share insights on key customer engagement challenges.
Ariel Katz, H1 | Frederik Bay, Adobe | Derek Choy, Aktana | Richard Schwartz, Qualtrics
In these discussions, panelists will share views on where they see commercial execution heading from a technology ecosystem view. What are the key influencing factors? What are the risks? How are these experts preparing for the continued wave of innovation we will see? Take away key practices and insights that you can immediately use to drive impact and value in your own organization.
Mike Soper, Biogen | John Walsh, Otsuka | Youssef Idelcaid, Genentech
In part two of the previous session, panelists will share views on where they see commercial execution heading from pharma's perspective.
John Vitalie | Aktana
The conclusion of the AIx agenda and recap of key discussions
Lunch is provided in the Networking Hub
Stick around to grab lunch before you go and continue the conversation.
Ira Haimowitz, Deloitte | Bingqian Gao, Aktana
What are the best ways to leverage data science and analytics to drive decision-making and enhance internal programs? In this breakout, you will learn how our presenters tackled challenges in building scalable frameworks and addressed internal processes, from implementing advanced analytics platforms to developing data governance policies.
Pete Stark, Veeva | Derek Choy, Aktana | Pini Ben-or, Aktana
Generative AI has taken over most conversations around AI. But where are the true impact opportunities for this innovation in commercial execution? What are the risks, and how do executive decision-makers invest in this quickly growing and evolving area? This discussion-based breakout will provide an opportunity to hear from pharma leaders and technology providers who are leading the charge in productizing this and other disruptive innovations.
Sybil Mathew, Novartis | Graham Rapier, Aktana
Once an organization has invested in supporting commercial teams with NBA programs, what are the challenges to achieving widespread adoption? What are the proven ways to go from implementation to effective use across teams? Hear our panelists share their learnings in delivering and evangelizing their NBA programs - and ultimately, what they say about the overall ROI of improving HCP engagement.
Mike Soper, Biogen | Victor Mora-Vandel, Novo Nordisk | Alan Kalton, Aktana
How do organizations optimize their investments in commercial intelligence and ensure what they are building is locally relevant but globally scalable? In this breakout session, you will hear how a global pharma company is establishing a foundation that brings together the technology, people and processes to ensure solution deployments have global efficiencies with maximum regional impact.
Allen Kumar, Biogen | Stan Tsvirko, Novartis | Dr. Deepak Patil, Aktana
Over the last decade, field medical teams have consistently expanded in size, scope and impact on the organization. Medical Science Liaisons are a trusted partner to physicians, enjoying more air time than any other pharmaceutical company stakeholder. How can AI-driven next best action (NBA) empower your medical affairs teams in effectively engaging with their stakeholders? Join us on a case-based discussion on unlocking the promise of NBA for medical affairs
Wendy Kampman, Regeneron | Thomas Yang, Deloitte | Dr. Deepak Patil, Aktana
A streamlined customer experience for physicians requires compliant collaboration among medical affairs, marketing and sales teams to ensure seamless handoffs. Join us for a discussion on best practices to drive alignment on common goals, and design the foundation of your omnichannel strategy.
Don't miss the opportunity to network and learn
from other leaders in commercial life sciences.
SIGN UP FOR AIX 2024 UPDATES